The results of the ALASCCA RCT, showing lower recurrence rate after adjuvant aspirin in patients with local CRC and PIK3CA mutations in exon 9 or 20, are published. As the PI in Finland I’d like to thank all collaborators at Meilahti and Jorvi Hospitals
www.nejm.org/doi/full/10....
Our PROSPERITY trial, comparing protective ileostomy and colostomy in anterior resection, will start soon. See the protocol in BMJ open bmjopen.bmj.com/content/bmjo...
08.05.2025 17:57 — 👍 0 🔁 0 💬 0 📌 0
For #ColorectalCancerAwarenessMonth, surgeon experts share insights into why the disease is affecting more younger adults, including patients in their 20s and 30s, and what can be done to prevent it.
🔗 Read their top 4️⃣ things to know: buff.ly/Zw6017o
March is Colorectal Cancer Awareness Month. Please go here for patient materials buff.ly/3EWWe7D
01.03.2025 20:00 — 👍 7 🔁 4 💬 0 📌 0
Prof Anna Martling presented results of #ALASCCA trial at #ASCOGI25, showing low dose aspirin reduce the recurrence rate by 50% in CRC-patients with tumors having mutations in the PI3K pathway. Proud of taking part in this trial with my team at Helsinki University Hospital, Colorectal Unit
26.01.2025 14:21 — 👍 7 🔁 2 💬 1 📌 0
Tumour deposit count is an independent prognostic factor in colorectal cancer—a population-based cohort study
➡️ doi.org/10.1093/bjs/...
Screen-detected colon cancer leads to better outcomes.
by Lucocq J, Trinder T (...) Muthukumarasamy G et 4 al. in World J Surg #Surgery #SurgSky #GeneralSurgery #MedSky
🪡 read our summary here
📖 read the article: https://onlinelibrary.wiley.com/doi/10.1002/wjs.12409
